Allworth Financial’s Sana Biotechnology SANA Stock Holding History

Allworth Financial’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.67K	Buy	1,338 +116	+9%	+$374	﹤0.01%	4152
2026 Q1	$3.52K	Buy	1,222 +55	+5%	+$217	﹤0.01%	4144
2025 Q4	$4.75K	Buy	1,167 +156	+15%	+$699	﹤0.01%	3743
2025 Q3	$3.59K	Buy	1,011 +459	+83%	+$1.66K	﹤0.01%	3723
2025 Q2	$1.51K	Buy	552 +342	+163%	+$706	﹤0.01%	3821
2025 Q1	$372	Sell	210 -103	-33%	-$288	﹤0.01%	3753
2024 Q4	$1.1K	Buy	313 +272	+663%	+$811	﹤0.01%	3364
2024 Q3	$171	Buy	+41	New	+$215	﹤0.01%	3627
2023 Q3	–	Sell	-33	Closed	-$197	–	3538
2023 Q2	$197	Buy	+33	New	+$190	﹤0.01%	3101
2023 Q1	–	Sell	-41	Closed	-$162	–	3278
2022 Q4	$162	Buy	+41	New	+$200	﹤0.01%	2836

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Allworth Financial's SANA Position: Q2 2026 in Review

Allworth Financial increased its Sana Biotechnology (SANA) stake by 9.5% in Q2 2026, buying an estimated $374 and bringing the position to 1,338 shares worth $4.67K. The position accounts for ﹤0.01% of the portfolio, ranked #4152.

Allworth Financial first reported a position in SANA in Q4 2022 and has held it in 10 quarters since. The position peaked at $4.75K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Allworth Financial held 1,338 shares of Sana Biotechnology worth $4.67K as of Q2 2026.
Allworth Financial bought 116 Sana Biotechnology shares in Q2 2026, an estimated $374.
Sana Biotechnology made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4152 holding.
Allworth Financial first reported a position in Sana Biotechnology in Q4 2022 and has held it in 10 quarters since.
Allworth Financial's Sana Biotechnology position peaked at $4.75K in Q4 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.